1
|
Dong L, Xie L, Li M, Dai H, Wang X, Wang P, Zhang Q, Liu W, Hu X, Zhao M. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma. Sci Rep 2019; 9:14854. [PMID: 31619714 PMCID: PMC6795893 DOI: 10.1038/s41598-019-51253-2] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2018] [Accepted: 09/28/2019] [Indexed: 01/13/2023] Open
Abstract
B7-H4, as a member of the B7 superfamily, was overexpressed in various types of cancers. However, the effects of B7-H4 on the aggressiveness of HCC and the underlying mechanisms have not yet been fully explored. For this purpose, B7-H4 expression was detected by Flow cytometry and Western blotting, it was highly expressed in several HCC cell lines but not in normal LO2 cell line. Knockdown B7-H4 expression induced HCC cells apoptosis by flow cytometry and colony formation assays and increased several apoptosis-related proteins, including survivin, cleaved caspase-3, cleaved caspase-7, and Bax, while the pro-growth protein survivin was reduced. Then the proliferation and cell cycle were suppressed after treated by siB7-H4. Moreover, the level of B7-H4 was significantly correlated with cell migration. In vivo, intra-tumor injection of siRNA targeting B7-H4 can significantly inhibited the growth of HepG2 cells in nude mice. Finally, regions of interest were manually traced on T1WI, T2WI, DWI and ADC of MR images. ADC values were increased in HCC xenografts after B7-H4 siRNA treatment. These data indicated that downregulation of B7-H4 suppressed the proliferation and migration and promoted apoptosis in vitro and in vivo. Blocking the B7-H4 channel might be a potential therapeutic strategy for HCC.
Collapse
Affiliation(s)
- Lijie Dong
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China.,Department of Radiology, Binzhou Medical University Hospital, Binzhou, Shandong, 256603, P.R. China
| | - Lulu Xie
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China
| | - Minjing Li
- Medicine & Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China
| | - Hanhan Dai
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China
| | - Xia Wang
- Department of Oral Pathology, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China
| | - Peiyuan Wang
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China
| | - Qiang Zhang
- Medicine & Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China
| | - Wei Liu
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China
| | - Xuemei Hu
- Department of Immunology, Binzhou Medical University, Yantai, Shandong, 264003, P.R. China.
| | - Mingdong Zhao
- Department of Imaging, Binzhou Medical University, Binzhou, Shandong, 264003, P.R. China.
| |
Collapse
|
2
|
Meng Y, Liu H, Bian N, Gong J, Zhong X, Huang C, Liang W, Xu H. In vitro study on human umbilical cord mesenchymal stem cells transfected with lentivirus-mediated hNIS-EGFP dual reporter gene and co-labeled with superparamagnetic iron oxide. Exp Ther Med 2018; 16:2208-2218. [PMID: 30186460 PMCID: PMC6122337 DOI: 10.3892/etm.2018.6505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2016] [Accepted: 05/05/2017] [Indexed: 01/10/2023] Open
Abstract
The aim of the present study was to establish a stem cell line for multi-mode imaging (in vivo fluorescence imaging, magnetic resonance imaging and 99mTc single-photon emission computed tomography) and to study the biological activity, stemness, proliferative activity and differentiation ability of superparamagnetic iron oxide (SPIO), human sodium/iodide symporter (hNIS) and enhanced green fluorescent protein (EGFP) co-labeled human umbilical cord mesenchymal stem cells (hUCMSCs). The EGFP reporter gene was selected to indirectly reflect the expression of target gene hNIS, and hUCMSCs were re-transfected with the successfully constructed recombinant plasmid pCMV-NIS-EF1-GFP-PGK-puro. When a stem cell line stably expressing hNIS and EGFP was obtained, the cells were incubated with 30 µg/ml SPIO to obtain hNIS, EGFP and SPIO co-labeled stem cells. The protein expressions of hNIS and EGFP were identified using western blot analysis, and the protein function of hNIS was identified by 125I influx and 125I efflux experiments. hNIS-EGFP-hUCMSCs were labeled with SPIO under the mediation of poly-L-lysine, and SPIO, hNIS and EGFP co-labeled hUCMSCs were established successfully. Staining with Prussian blue confirmed that 98% of cells were successfully labeled with SPIO. Western blotting results demonstrated positive hNIS and EGFP protein expression levels, and 125I influx and 125I efflux experiments confirmed that the protein function of hUCMSCs after expressing hNIS was normal. The uptake of 125I was higher in cell lines hNIS-EGFP-hUCMSCs than in control hUCMSCs (fold change: 16.43±2.30 times; P<0.05). The stemness of hNIS-EGFP-hUCMSCs was found to be slightly decreased but not statistically significant; the overall characteristics of stem cells remained unchanged. The assessments of adipogenic and osteogenic differentiation suggest that hNIS-EGFP-hUCMSCs have no significantly different characteristics compared with primary hUCMSCs.
Collapse
Affiliation(s)
- Yu Meng
- Department of Nephrology, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Huanhuan Liu
- Department of Nephrology, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Ning Bian
- Department of Cardiovascular Medicine, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Jian Gong
- Department of Nuclear Medicine, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Xing Zhong
- Department of Nuclear Medicine, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Chunrong Huang
- Department of Nephrology, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Wenxue Liang
- Department of Nephrology, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| | - Hao Xu
- Department of Nephrology, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China.,Department of Nuclear Medicine, The First Hospital Affiliated to Jinan University, Guangzhou, Guangdong 510630, P.R. China
| |
Collapse
|
3
|
Lin Q, Wang H, Lin X, Zhang W, Huang S, Zheng Y. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR. Cancer Biother Radiopharm 2018; 33:60-64. [PMID: 29634414 DOI: 10.1089/cbr.2017.2254] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVE Nasopharyngeal carcinoma (NPC) shows the leading morbidity in otorhinolaryngological malignant tumor. It is a common malignancy in China with obvious reginal distribution. NPC is a polygenic disease that is affected by numerous factors. Protein tyrosine phosphatase nonreceptor type 12 (PTPN12) regulates multiple tumor proliferation and development, including breast cancer and colon cancer. However, the role of PTPN12 in NPC occurrence and development has not been elucidated. PATIENTS AND METHODS NPC cell line CNE2 was cultured in vitro and divided into three groups, including control, empty plasmid, and PTPN12 groups. PTPN12 mRNA and protein expressions were tested by real-time polymerase chain reaction and Western blot. CNE2 cell proliferation was detected by MTT assay. Cell migration was determined by wound healing assay. Cell apoptosis was evaluated by caspase 3 activity detection. Epidermal growth factor receptor (EGFR) expression was assessed by Western blot. RESULTS PTPN12 plasmid transfection increased PTPN12 mRNA and protein expressions, suppressed cell proliferation and migration, reduced EGFR level, and enhanced caspase 3 activity compared with control and empty plasmid groups (p < 0.05). CONCLUSIONS PTPN12 regulates NPC proliferation and migration through negative regulating EGFR. It could be treated as a molecular target for NPC diagnosis and prognosis analysis.
Collapse
Affiliation(s)
- Qinghai Lin
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| | - Huige Wang
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| | - Xinqiang Lin
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| | - Wenrui Zhang
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| | - Shuhua Huang
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| | - Yandan Zheng
- Department of Otolaryngology, First Affiliated Hospital of Shantou University Medical College , Shantou, Guangdong, China
| |
Collapse
|
4
|
Dai J, Wu W, Zhou J, Gao K, Hu G, Lin C, Zhang Y, Li X. Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanism. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 2015; 8:6057-6063. [PMID: 26261483 PMCID: PMC4525817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 03/12/2015] [Accepted: 04/26/2015] [Indexed: 06/04/2023]
Abstract
BACKGROUND Rectal cancer seriously threats to human health. Traditional chemotherapy drugs might kill rectal cancer cells while easy cause side effects and clinical complications. Therefore, it is necessary to explore possible new methods for rectal cancer treatment. Survivin is an important tumor-specific protein. Previous researches showed it may be closely related to nasopharyngeal carcinoma. Its role in rectal cancer remains unclear. METHODS Cultivate human rectal cancer HRC-9698 cells. Antisense microRNA targeting survivin and control miRNA were constructed and transfected to HRC-9698 cells. MTT assay was applied to detect cell growth. Flow cytometry was used to test cell apoptosis. Western blot was performed to detect Osteopontin expression level. Colony formation and transwell assay were used to test cell clone formation and invasion abilities. RESULTS Antisense microRNA targeting survivin can inhibit HRC-9698 cell proliferation and induce its apoptosis. Antisense microRNA targeting survivin decreased osteopontin expression level. Overexpressed osteopontin inhibited antisense microRNA targeting survivin induced cell apoptosis. Antisense microRNA targeting survivin suppressed HRC-9698 cells' colony formation and invasion abilities. CONCLUSION Antisense microRNA targeting survivin induced osteopontin participated HRC-9698 cell apoptosis. Antisense microRNA targeting survivin inhibited HRC-9698 cell colony formation and invasive abilities, indicating that survivin may play its anti-tumor effect through inducing cell apoptosis and inhibiting cell metastasis and invasion.
Collapse
Affiliation(s)
- Jing Dai
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Wei Wu
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Jianyu Zhou
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Kai Gao
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Gui Hu
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Changwei Lin
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Yi Zhang
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| | - Xiaorong Li
- Department of General Surgery, The Third Xiang Ya Hospital of Central South University Changsha, Hunan 410013, P. R. China
| |
Collapse
|